š¬ Current Disease Focus:
Task Progress: 0%
š„ Active Problem Solvers
0
š Experts collaborating globally
ā” Current Task Assignment
š§¬ Genetic Analysis
š Matching experts to specific tasks
š Resource Allocation by Research Phase:
š Data Analysis
š§Ŗ Experimental Design
š¬ Clinical Trials
š Treatment Development
This prospective observational study aims to evaluate the efficacy, safety ...
Status
Unknown
Location
Endoscopy Unit, Gastroenterology Department, Humanitas Research Hospital
Start Date
2024-07-01
Trial ID
NCT06435377
Treatments Being Tested
Conventional supplemental oxygen therapy (COT) during upper gastrointestina...
Status
Completed
Location
Ain Shams University-Faculty of Medicine
Start Date
2024-04-10
Trial ID
NCT06350864
Emergency medical service (EMS) vehicles are exposed to a wide range of env...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-07-01
Trial ID
NCT07646964
The study will begin with a two-week lead-in period (W-2 and W-1), when par...
Status
Recruiting
Location
RDSS Research Center
Start Date
2023-07-20
Trial ID
NCT06676410
Treatments Being Tested
This is a multicenter, non interventional, retrospective cohort study with ...
Status
Completed
Location
Study Site
Start Date
2015-05-07
Trial ID
NCT02427217
Treatments Being Tested
The objective of this study is to investigate the feasibility for the treat...
Status
Unknown
Location
University Hospital Hamburg-Eppendorf
Start Date
2023-12-06
Trial ID
NCT06435533
Treatments Being Tested
Injectable platelet-rich fibrin (I-PRF) is a flowable blood concentrate tha...
Status
Unknown
Location
Multiple Locations
Start Date
2018-11
Trial ID
NCT03698188
Treatments Being Tested
Objectives: Study to evaluate safety and feasibility of an endoluminal vert...
Status
Completed
Location
Erasme Hospital , ULB
Start Date
2015-05
Trial ID
NCT02534662
Treatments Being Tested
The primary objective of the study is to evaluate the effectiveness of prop...
Status
Terminated
Location
Research Site
Start Date
2015-07
Trial ID
NCT02392156
Treatments Being Tested
Primary Objective: ā¢ To evaluate the safety and tolerability of cAd3-EBO-S...
Status
Completed
Location
Oklahoma Blood Institute (OBI)
Start Date
2021-01-06
Trial ID
NCT04723602
Treatments Being Tested